Previous studies indicated that anti-PD medications, such as catechol-O-methyltransferase (COMT) inhibitors, amantadine and monoamine oxidase B (MAO-B) inhibitors, might interfere with the results of microbiotal alterations analysis15–17. The gene discussed is COMT; the disease is Parkinson disease.